HCID 10049155, compound → HCID 10071379, compound
Reaction equation
[Cl:1][C:2]1[CH:6]=[CH:5][S:4][C:3]=1[C:7]([N:9]1[CH2:14][CH2:13][CH:12]([N:15]2[CH2:20][CH2:19][CH:18]([N:21]3[C:25]4[CH:26]=[CH:27][CH:28]=[CH:29][C:24]=4[NH:23][C:22]3=[O:30])[CH2:17][CH2:16]2)[CH2:11][CH2:10]1)=O.[H-].[Al+3].[Li+].[H-].[H-].[H-]>C1COCC1>[Cl:1][C:2]1[CH:6]=[CH:5][S:4][C:3]=1[CH2:7][N:9]1[CH2:14][CH2:13][CH:12]([N:15]2[CH2:20][CH2:19][CH:18]([N:21]3[C:25]4[CH:26]=[CH:27][CH:28]=[CH:29][C:24]=4[NH:23][C:22]3=[O:30])[CH2:17][CH2:16]2)[CH2:11][CH2:10]1Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 0 °C
Procedure
A suspension of 29.7 mg of 1-[1-[1-(3-Chloro-2-thenoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one and 7 mg of lithium aluminum hydride in 1 ml of THF was stirred at 0° C. for 2 h and then quenched with Na2SO4—10H2O. The mixture was stirred overnight and the insoluble material was removed by filtration. The filtrate was concentrated and purified with PTLC (CHCl3/MeOH/28% aqueous NH3=120/10/1) to give 11.0 mg of the target compound as a colorless solid.
Workup
- customquenched with Na2SO4—10H2O
- stirringThe mixture was stirred overnight
- customthe insoluble material was removed by filtration
- concentrationThe filtrate was concentrated
- custompurified with PTLC (CHCl3/MeOH/28% aqueous NH3=120/10/1)
Sources & evidence
- ORD record
- ord-cbb7db3316f14b60932d01a62b0e338d
- Source dataset
- uspto-grants-2007_10
- Patent number
- US07279490B2
Reaction notes
Loading…